Senior Director, Investor Relations & Corporate Communications at Odyssey Therapeutics

Boston, Massachusetts, United States -

Full Time

Start Date

Immediate

Expiry Date

13 Aug, 26

Salary

0.0

Posted On

15 May, 26

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Investor Relations, Corporate Communications, SEC Disclosure, Financial Media Relations, Public Affairs, Biotechnology Communications, Crisis Management, Strategic Messaging, Market Intelligence, Regulatory Compliance, Clinical Data Narrative, Stakeholder Management, Financial Reporting, Public Relations, Executive Coaching, Digital IR Platforms

Industry

Biotechnology Research

Description

The Senior Director, Investor Relations & Corporate Communications is a pivotal leadership role responsible for developing and executing a comprehensive investor relations and corporate communications strategy for the company. Reporting to the Head of Strategy & BD, this individual will serve as a primary point of contact for the investment community, equity research analysts, and the financial media, while also overseeing corporate messaging, media relations, and public affairs. The ideal candidate is an experienced life sciences investor relations professional who thrives at the intersection of science, finance, and narrative development, and who brings deep expertise in managing the communications demands of a publicly traded biotech company. Investor Relations * Develop and manage the company's investor relations program, including the annual IR strategy, messaging framework, and engagement calendar * Serve as a spokesperson for the investment community, managing relationships with investors and sell-side analysts, institutional investors, and retail shareholders * Prepare and deliver investor presentations, earnings call press releases and scripts, Q&A materials, and analyst day content in collaboration with the CEO, CFO, and Head of Strategy & BD * Monitor analyst coverage, market intelligence, investor holdings, competitors, and peer company activities; provide regular briefings and competitive analyses to senior leadership * Collaborate with Finance and the General Counsel on all SEC-required disclosures and financial communications, ensuring accuracy, regulatory compliance, and consistent messaging * Coordinate the company's participation in healthcare and biotech investor conferences, non-deal roadshows, and key industry events * Develop and maintain the investor relations section of the corporate website and manage investor-facing digital content and communications Corporate Communications * Build and execute a proactive corporate communications strategy that conveys the company's scientific vision, pipeline progress, and corporate milestones to a broad range of audiences * Manage relationships with external PR agency, financial communications firms, and media contacts across healthcare, biotech, and financial press * Draft, edit, and oversee the distribution of press releases, corporate announcements, and media statements, ensuring alignment with regulatory requirements and corporate messaging * Develop and maintain key message documents, scientific background files, and corporate fact sheets for internal and external stakeholders * Prepare executives for media interviews, conference presentations, and investor meetings and serve as a spokesperson as appropriate * Develop and maintain the corporate website * Oversee the company's corporate social media strategy and ensure consistency of voice across all digital and external channels Clinical & Pipeline Communications * Partner with the Chief Medical Officer and clinical development team to craft clear, accurate communications around clinical trial milestones, data readouts, and regulatory interactions * Translate complex scientific and clinical data into compelling narratives appropriate for investor, media, and patient audiences * Prepare materials and messaging in advance of anticipated clinical data releases, ensuring proper legal review and disclosure protocols Leadership & Cross-Functional Collaboration * Work closely with the CEO, CFO, CMO, General Counsel, and Head of Strategy & BD to align communications with corporate objectives and ensure consistent messaging across all channels * Manage relationships with outside IR advisory firms, and other relevant service providers * Bachelor's degree required with minimum 8 years of progressive experience in investor relations, corporate communications, finance or a combination thereof, with at least 5 years in the biotechnology or pharmaceutical sector * Direct experience supporting a publicly traded company, including with thorough knowledge of SEC disclosure requirements, Regulation FD, and public company communications best practices * Demonstrated track record of managing investor relations programs through clinical data events, follow-on transactions, and other significant corporate milestones * Exceptional written and verbal communication skills, with the ability to distill complex scientific and financial information for diverse audiences * Strong existing relationships with healthcare-focused buy-side and sell-side analysts and financial media * Expertise in inflammation and immunology therapeutic areas preferred; experience across other therapeutic areas will also be considered * Ability to thrive in a fast-paced, entrepreneurial environment and manage multiple priorities simultaneously * Willingness to travel as needed for investor events and conferences Preferred * Expertise in inflammation and immunology therapeutic areas preferred; experience across other therapeutic areas will also be considered * Familiarity with key opinion leader (KOL) engagement strategies and patient advocacy communications in inflammatory or immunological disease areas * Experience with social media platforms (e.g., LinkedIn and X) * Experience with digital IR platforms (e.g., Q4 IR, Notified/PR Newswire, Bloomberg Intelligence)

Responsibilities

Develop and execute a comprehensive investor relations and corporate communications strategy to manage the company's narrative for the investment community and financial media. Oversee SEC disclosures, clinical trial communications, and corporate messaging to align with business objectives.